4//SEC Filing
Hayon Yael 4
Accession 0001104659-20-082116
CIK 0001006281other
Filed
Jul 7, 8:00 PM ET
Accepted
Jul 8, 5:01 PM ET
Size
5.8 KB
Accession
0001104659-20-082116
Insider Transaction Report
Form 4
Hayon Yael
VP, Research & Development
Transactions
- Award
Stock Options (Right to Buy)
2020-07-05+129,771→ 129,771 totalExercise: $3.73Exp: 2030-07-05→ Common Stock (129,771 underlying)
Footnotes (1)
- [F1]The shares of common stock underlying the stock options shall vest in 16 equal quarterly installments commencing upon the date of grant. The stock options are subject to accelerated vesting upon a corporate transaction or a change in control as described in the Protalix BioTherapeutics, Inc., Amended and Restated 2006 Stock Incentive Plan, as amended.
Documents
Issuer
Protalix BioTherapeutics, Inc.
CIK 0001006281
Entity typeother
Related Parties
1- filerCIK 0001817121
Filing Metadata
- Form type
- 4
- Filed
- Jul 7, 8:00 PM ET
- Accepted
- Jul 8, 5:01 PM ET
- Size
- 5.8 KB